These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups. Corte JR; Pinto DJP; Fang T; Osuna H; Yang W; Wang Y; Lai A; Clark CG; Sun JH; Rampulla R; Mathur A; Kaspady M; Neithnadka PR; Li YC; Rossi KA; Myers JE; Sheriff S; Lou Z; Harper TW; Huang C; Zheng JJ; Bozarth JM; Wu Y; Wong PC; Crain EJ; Seiffert DA; Luettgen JM; Lam PYS; Wexler RR; Ewing WR J Med Chem; 2020 Jan; 63(2):784-803. PubMed ID: 31833761 [TBL] [Abstract][Full Text] [Related]
7. Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors. Priestley ES; Cheney DL; DeLucca I; Wei A; Luettgen JM; Rendina AR; Wong PC; Wexler RR J Med Chem; 2015 Aug; 58(15):6225-36. PubMed ID: 26151189 [TBL] [Abstract][Full Text] [Related]
8. Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitors. Hu Z; Wang C; Han W; Rossi KA; Bozarth JM; Wu Y; Sheriff S; Myers JE; Luettgen JM; Seiffert DA; Wexler RR; Quan ML Bioorg Med Chem Lett; 2018 Apr; 28(6):987-992. PubMed ID: 29501396 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of macrocyclic indoles targeting blood coagulation cascade Factor XIa. Hanessian S; Larsson A; Fex T; Knecht W; Blomberg N Bioorg Med Chem Lett; 2010 Dec; 20(23):6925-8. PubMed ID: 21035339 [TBL] [Abstract][Full Text] [Related]
10. Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design. Fjellström O; Akkaya S; Beisel HG; Eriksson PO; Erixon K; Gustafsson D; Jurva U; Kang D; Karis D; Knecht W; Nerme V; Nilsson I; Olsson T; Redzic A; Roth R; Sandmark J; Tigerström A; Öster L PLoS One; 2015; 10(1):e0113705. PubMed ID: 25629509 [TBL] [Abstract][Full Text] [Related]
11. Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species. Yang W; Wang Y; Lai A; Clark CG; Corte JR; Fang T; Gilligan PJ; Jeon Y; Pabbisetty KB; Rampulla RA; Mathur A; Kaspady M; Neithnadka PR; Arumugam A; Raju S; Rossi KA; Myers JE; Sheriff S; Lou Z; Zheng JJ; Chacko SA; Bozarth JM; Wu Y; Crain EJ; Wong PC; Seiffert DA; Luettgen JM; Lam PYS; Wexler RR; Ewing WR J Med Chem; 2020 Jul; 63(13):7226-7242. PubMed ID: 32456431 [TBL] [Abstract][Full Text] [Related]